Natera's total revenues decrease 2.9% to $44.9 million in third quarter 2015
 

Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the third quarter ended September 30, 2015 and provided an update on recent business progress.

More...